Business Context and Reporting Period
This Form 8-K was filed by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) on March 25, 2015. The report details significant changes to the Company's Board of Directors and executive management effective April 1, 2015, including the resignation of a director, the election of a new director, and the termination of a Named Executive Officer.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and personnel changes.
Material Changes
- Resignation of Director: Michael J. Ryan resigned from the Board of Directors effective April 1, 2015. His departure was voluntary and not the result of any disagreement with the Company.
- Election of New Director: Francis P. Grillo, the Company's Chief Executive Officer and President, was elected to the Board effective April 1, 2015.
- Termination of Executive Officer: Kimble L. Jenkins will separate from employment as an officer effective April 1, 2015, though he will remain as Chairman of the Board.
Compensation, Outlook, and Risks
Compensatory Arrangements:
- Michael J. Ryan: The Compensation Committee accelerated the vesting of two stock options (45,000 shares and 20,000 shares) and extended the exercise period for three option awards through April 1, 2017.
- Kimble L. Jenkins: Upon termination, Mr. Jenkins' stock options will immediately vest. He will enter a consulting agreement to assist with the transition of operations from Memphis to Irvine and business development matters, compensated on an hourly basis.
Outlook and Risks: The filing does not contain specific financial guidance or risk factors. The management transition is described as previously announced, with Mr. Grillo's election attributed to his experience in driving the adoption of new medical technologies.
Investor Verification Checklist
- Verify the effective date of the management transition (April 1, 2015).
- Confirm the specific number of shares subject to accelerated vesting for departing director Michael J. Ryan.
- Review the terms of the consulting agreement for Kimble L. Jenkins regarding hourly compensation rates.
- Check subsequent filings for the impact of the operational move from Memphis, Tennessee, to Irvine, California.